Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.76p
   
  • Change Today:
      0.003p
  • 52 Week High: 3.96
  • 52 Week Low: 1.17
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 7,822,292
  • Market Cap: £23.62m
  • RiskGrade: 340

London pre-open: Stocks seen a little lower after healthy gains

By Michele Maatouk

Date: Wednesday 30 Dec 2015

LONDON (ShareCast) - (ShareCast News) - London stocks are expected to open a little lower on Wednesday amid holiday-thinned volumes, following healthy gains in the previous session.
The FTSE 1000 is called to open 16 points lower than Tuesday's close at 6,298 on what will be the final full trading day of 2015.

There is no major UK data due but Eurozone M3 money supply is at 0900 GMT. In the US, MBA mortgage applications are at 1200 GMT, while pending home sales are at 1500 GMT.

Regional REIT buys £37.5m portfolio

Recently-listed commercial property company Regional REIT has exchanged contracts to purchase five assets from a retained client of La Salle Investment Management for a total consideration of £37.5m in an off-market deal.

The transaction, which is likely to complete by the end of January 2016, is expected to provide a net income of £3.38m a year, equating to a yield of 8.25%. It will be funded from the company's existing resources.

Mirada plc, the AIM-quoted leading audiovisual content interaction specialist, said it reduced interim pre-tax losses to £0.81m from £0.88m.

Revenues rose to £2.26m from £2.19m with earnings before interest, tax and depreciation up to £0.18m from a loss of £0.09m last time.

Mirada said it expected a further increase in EBITDA once the Mexico City Televisa networks start their commercial roll out of its set top box and interactive technology "Inspire" product.

Fully-listed cash shell Silver Falcon has agreed to make an initial acquisition, with a reverse takeover planned of unlisted insurance automation technology firm Lime Holdings.

Silver Falcon, which listed in November with a buy-and-build strategy focused on the 'fintech' industry, was forced to suspend its shares last week after major anticipatory spikes in its share price.

While the company has reached an agreement with Lime's management, the terms are subject to due diligence, a fundraising, and re-listing of the enlarged group

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.76p
Change Today 0.003p
% Change -0.14 %
52 Week High 3.96
52 Week Low 1.17
Volume 7,822,292
Shares Issued 1,341.82m
Market Cap £23.62m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.48% below the market average47.48% below the market average47.48% below the market average47.48% below the market average47.48% below the market average
70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average
Price Trend
10.63% below the market average10.63% below the market average10.63% below the market average10.63% below the market average10.63% below the market average
43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:29 300,000 @ 1.74p
16:29 5,023 @ 1.74p
16:28 174,147 @ 1.73p
16:19 114,621 @ 1.74p
15:46 13,566 @ 1.75p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page